跳至主要内容
临床试验/NL-OMON42473
NL-OMON42473已完成不适用

YMFOcare: The impact of providing feedback on patients* symptoms and health-related quality of life and offering a self-management website on the self-management of patients with lymphoma. A randomized controlled population-based registry trial. - LYMFOcare

Integraal Kankercentrum Nederland (IKNL)0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All patients (men and women) that are newly diagnosed with Hodgkin or non-Hodgkin lymphoma in one of the participating hospitals and were 18 years or older at time of diagnosis.

排除标准

  • Unable to complete a Dutch questionnaire.
  • Patients with severe psychopathology or dementia.

研究者

发起方
Integraal Kankercentrum Nederland (IKNL)

相似试验

YMFOcare: The impact of providing feedback on... | 临床试验